The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Biochemical Sequence Analyses of GES-1, a Novel Class A Extended-Spectrum β-Lactamase, and the Class 1 Integron In52 from Klebsiella pneumoniae
Open accessAbstract
Klebsiella pneumoniae ORI-1 was isolated in 1998 in France from a rectal swab of a 1-month-old girl who was previously hospitalized in Cayenne Hospital, Cayenne, French Guiana. This strain harbored a ca. 140-kb nontransferable plasmid, pTK1, that conferred an extended-spectrum cephalosporin resistance profile antagonized by the addition of clavulanic acid, tazobactam, or imipenem. The gene for GES-1 (Guiana extended-spectrum β-lactamase) was cloned, and its protein was expressed in Escherichia coli DH10B, where this pI-5.8 β-lactamase of a ca. 31-kDa molecular mass conferred resistance to oxyimino cephalosporins (mostly to ceftazidime). GES-1 is weakly related to the other plasmid-located Ambler class A extended-spectrum β-lactamases (ESBLs). The highest percentage of amino acid identity was obtained with the carbenicillinase GN79 from Proteus mirabilis ; with YENT, a chromosome-borne penicillinase from Yersinia enterocolitica ; and with L-2, a chromosome-borne class A cephalosporinase from Stenotrophomonas maltophilia (36% amino acid identity each). However, a dendrogram analysis showed that GES-1 clustered within a class A ESBL subgroup together with ESBLs VEB-1 and PER-1. Sequencing of a 7,098-bp DNA fragment from plasmid pTK1 revealed that the GES-1 gene was located on a novel class 1 integron named In52 that was characterized by (i) a 5′ conserved segment containing an intI1 gene possessing two putative promoters, P 1 and P 2 , for coordinated expression of the downstream antibiotic resistance genes and an attI1 recombination site; (ii) five antibiotic gene cassettes, bla GES-1 , aac(6′)Ib ′ (gentamicin resistance and amikacin susceptibility), dfrXVb (trimethoprim resistance), a novel chloramphenicol resistance gene ( cmlA4 ), and aadA2 (streptomycin-spectinomycin resistance); and (iii) a 3′ conserved segment consisting of qacEΔ1 and sulI . The bla GES-1 and aadA2 gene cassettes were peculiar, since they lacked a typical 59-base element. This work identified the second class A ESBL gene of a non-TEM, non-SHV series which was located in the plasmid and integron, thus providing it additional means for its spread and its expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Fundamentals of Enzyme Kinetics
(1979) · Elsevier eBooks · doi:10.1016/c2013-0-04130-8 · Cited by 2,059
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Stokes, H. W., & Hall, R. M. (1989) · Molecular Microbiology · doi:10.1111/j.1365-2958.1989.tb00153.x · Cited by 885
Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.
Sutcliffe, J. G. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3737 · Cited by 782
Mobile gene cassettes and integrons: capture and spread of genes by site‐specific recombination
Hall, R. M., & Collis, C. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02368.x · Cited by 774
Cited by
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Carbapenem resistance in Enterobacteriaceae: here is the storm!
Nordmann, P., Dortet, L., & Poirel, L. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.003 · Cited by 1,038
Self-citationPast and Present Perspectives on β-Lactamases
Bush, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-18 · Cited by 832
Molecular basis of bacterial resistance to chloramphenicol and florfenicol
Schwarz, S., Kehrenberg, C., Doublet, B., & Cloeckaert, A. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.04.001 · Cited by 800
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Castanheira, M., Simner, P. J., & Bradford, P. A. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab092 · Cited by 796
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.08.002 · Cited by 758
Carbapenem resistance: overview of the problem and future perspectives
Meletis, G. (2016) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936115621709 · Cited by 725
Potron, A., Poirel, L., & Nordmann, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.001 · Cited by 688
Self-citationGene cassettes and cassette arrays in mobile resistance integrons
Partridge, S. R., Tsafnat, G., Coiera, E., & Iredell, J. R. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00175.x · Cited by 680
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
Nordmann, P., & Poirel, L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12719 · Cited by 679
Self-citationPrevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe
Cantón, R., Novais, A., Valverde, A., Machado, E., Peixe, L., Baquero, F., & Coque, T. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01850.x · Cited by 599
Extended-spectrum ß-lactamases in gram negative bacteria
Rawat, D., & Nair, D. (2010) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.68531 · Cited by 588
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
Pfeifer, Y., Cullik, A., & Witte, W. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.005 · Cited by 494
Modes and Modulations of Antibiotic Resistance Gene Expression
Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., & Courvalin, P. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00015-06 · Cited by 427
Resistance integrons and super-integrons
Fluit, A. C., & Schmitz, F.-J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1198-743x.2004.00858.x · Cited by 419
Goldstein, C., Lee, M. D., Sanchez, S., Hudson, C., Phillips, B., Register, B., Grady, M., Liebert, C., Summers, A. O., White, D. G., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.723-726.2001 · Cited by 385
Rupp, M. E., & Fey, P. D. (2003) · Drugs · doi:10.2165/00003495-200363040-00002 · Cited by 379
Nnadozie, C. F., & Odume, O. N. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113067 · Cited by 365
Poirel, L., Decousser, J.-W., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2938-2945.2003 · Cited by 357
Self-citationSaladin, M., Cao, V. T. B., Lambert, T., Donay, J.-L., Herrmann, J.-L., Ould-Hocine, Z., Verdet, C., Delisle, F., Philippon, A., & Arlet, G. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11126.x · Cited by 348
Néron, B., Littner, E., Haudiquet, M., Perrin, A., Cury, J., & Rocha, E. (2022) · Microorganisms · doi:10.3390/microorganisms10040700 · Cited by 319
Paterson, D. L. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00107.x · Cited by 310
Carbapenemases: Molecular Diversity and Clinical Consequences
Poirel, L., Pitout, J. D., & Nordmann, P. (2007) · Future Microbiology · doi:10.2217/17460913.2.5.501 · Cited by 309
Self-citationSawa, T., Kooguchi, K., & Moriyama, K. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-0429-6 · Cited by 296
Walther-Rasmussen, J., & Høiby, N. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm226 · Cited by 271
Bahr, G., González, L. J., & Vila, A. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00138 · Cited by 266
Poirel, L., Kämpfer, P., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.4038-4040.2002 · Cited by 266
Self-citationRowe-Magnus, D. A., Guerout, A.-M., Ploncard, P., Dychinco, B., Davies, J., & Mazel, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.652 · Cited by 257
Metadata
- Authors
- Poirel, L., Le Thomas, I., Naas, T., Karim, A., & Nordmann, P.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2000-03
- Volume
- 44
- Issue
- 3
- Pages
- 622-632
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2167789296
- Cited by
- 421
- References
- 53
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.